Se connecter Inscription gratuite

Nymox Pharmaceutical Corp Quick ratio

Quel est le Quick ratio de Nymox Pharmaceutical Corp?

Le Quick ratio de Nymox Pharmaceutical Corp est 1.15

Quelle est la définition de Quick ratio?



«Quick ratio» est le ratio de liquidité qui mesure la capacité d'une entreprise à utiliser ses actifs rapides pour faire face à ses obligations à court terme immédiatement.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio des entreprises dans Health Care secteur sur NASDAQ par rapport à Nymox Pharmaceutical Corp

Que fait Nymox Pharmaceutical Corp?

nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.

Entreprises avec quick ratio similaire à Nymox Pharmaceutical Corp